 | |||||
| cannabidiol for epilepsy | |||||
| NEWS | |||||
| Could GW Pharmaceuticals Be a Millionaire-Maker Stock? GW Pharmaceuticals markets Epidolex (cannabidiol) for the treatment of seizures caused by two rare forms of epilepsy. In the first quarter of 2020, ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
